Adolescents / TeensKidsFamily PracticeOBGYN & Women's HealthHematology & OncologyPediatricsInternal MedicineCancerTeensChild HealthGeneral HealthSurvival
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Feb. 20, 2020 (HealthDay News) -- Early-adolescent and young adult cancer survivors have increased mortality and morbidity risks compared with siblings or the general population, according to a study published online Feb. 14 in The Lancet Oncology.
Eugene Suh, M.D., from Loyola University Chicago Health Sciences, and colleagues used data from the Childhood Cancer Survivor Study to describe chronic health conditions and all-cause and cause-specific mortality among survivors of early-adolescent and young adult cancer (aged 15 to 20 years at diagnosis; 5,804 survivors) and survivors diagnosed at an age younger than 15 years (5,804 survivors) compared with a cohort of siblings and the general population.
The researchers found that the standardized mortality ratio (SMR) for all-cause mortality was 5.9 and 6.2 among early-adolescent and young adult survivors and childhood cancer survivors, respectively, compared with the general population. Compared with childhood cancer survivors, early-adolescent and young adult cancer survivors had lower SMRs for death from health-related causes (SMR, 4.8 versus 6.8), which was mainly evident more than 20 years after cancer diagnosis. The risk for developing severe and disabling, life-threatening, or fatal health conditions was increased for early-adolescent and young adult cancer survivors and childhood cancer survivors versus siblings of the same age (hazard ratios, 4.2 and 5.6, respectively).
"Our data underscore that focused efforts are needed to ensure early-adolescent and young adult cancer survivors are receiving recommended risk-based care, with a focus on high-risk cancer screening, to reduce morbidity and premature mortality," the authors write.
One author disclosed financial ties to Novo Nordisk.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 26, 2022
Read this Next
Other Trending Articles